Results 161 to 170 of about 299,630 (303)

Profile of Tau-Associated Selected MicroRNAs in Hospitalized COVID-19 Patients: An Exploratory Single-Center Study. [PDF]

Cells
Carbone E, Zingaropoli MA, Perrone F, Talarico G, Pasculli P, Minni A, Petrella C, Barbato C, Piscopo P.   +8 more
europepmc   +1 more source

Intestinal microbiome alterations in pediatric epilepsy: Implications for seizures and therapeutic approaches

Epilepsia Open, EarlyView.
Abstract The intestinal microbiome plays a pivotal role in maintaining host health through its involvement in gastrointestinal, immune, and central nervous system (CNS) functions. Recent evidence underscores the bidirectional communication between the microbiota, the gut, and the brain and the impact of this axis on neurological diseases, including ...
Teresa Ravizza, Greta Volpedo, Antonella Riva, Pasquale Striano, Annamaria Vezzani   +4 more
wiley   +1 more source

Clinical phenotype and laboratory markers in patients affected by haploinsufficiency of A20 (HA20): a case series from two Italian centres. [PDF]

RMD Open
De Nardi L, Federici S, De Martino E, Celani C, Girardelli M, Matteo V, Caiello I, Passarelli C, Perrone C, Prencipe G, Tesser A, Pin A, Pastore S, Bramuzzo M, De Benedetti F, Tommasini A, Insalaco A.   +16 more
europepmc   +1 more source

Perspectives on the burden of drug‐resistant epilepsy and treatment priorities: Findings from a multistakeholder survey

Epilepsia Open, EarlyView.
Abstract Objective Drug‐resistant epilepsy (DRE) imposes a significant burden on patients and their caregivers. This study aimed to explore the concerns and perceptions of healthcare providers (HCPs), patients, and caregivers regarding the burden of disease and quality of life (QoL) in patients with DRE.
Simona Lattanzi, Bettina Schmitz, Nuno Canas, John Paul Leach, Caroline Benoist, Daniela Pierucci, Elena Álvarez‐Barón   +6 more
wiley   +1 more source

Mapping the regulatory landscape for environmental sustainability of medical device practices within the European Union. [PDF]

Eur J Public Health
Zarro M, Ferranti A, Garagozzo G, Fico G, Pecchia L.   +4 more
europepmc   +1 more source

Real‐world effectiveness of highly purified cannabidiol in epilepsy associated with 15q11.2‐q13.1 duplication and deletion syndromes: A multicenter study

Epilepsia Open, EarlyView.
Abstract This multicenter retrospective study evaluated the effectiveness and safety of highly purified cannabidiol (CBD) in 22 patients with 15q11.2‐q13.1 duplication or deletion syndromes (15q‐DDS), including 12 with 15q duplication syndrome (dup15q) and 10 with Angelman syndrome (AS). Median (interquartile range [IQR]) age at CBD initiation was 14.5
Emanuele Cerulli Irelli, Adolfo Mazzeo, Marco Perulli, Georgia Ramantani, Domenica Battaglia, Irene Bagnasco, Erica Cognolato, Pasquale Striano, Susanna Negrin, Alberto Danieli, Paolo Bonanni, Francesca F. Operto, Carlo Di Bonaventura, Antonietta Coppola, Alessandro Orsini   +14 more
wiley   +1 more source

The topographical distribution of spermatogonial subpopulations during the cycle of seminiferous epithelium in Macaca Fascicularis. [PDF]

Biol Reprod
Palazzoli M, Capponi C, Di Persio S, Fera S, Filippini A, Schlatt S, Neuhaus N, Vicini E.   +7 more
europepmc   +1 more source

Consumer Protection Choice of Law: European Lessons for the United States [PDF]

, 2009
Healy, James J.
core   +1 more source

Effectiveness of adjunctive low‐dose clobazam in adults with focal drug‐resistant epilepsy and incomplete response to cenobamate: A real‐world study

Epilepsia Open, EarlyView.
Abstract Objective Cenobamate (CNB) is a highly effective antiseizure medication (ASM) for focal drug‐resistant epilepsy (DRE); nevertheless, even with CNB treatment and optimized therapy, a substantial proportion of patients continued to experience seizures.
Ilaria Ciullo, Alfredo D'Aniello, Chiara Panzini, Enrico Michele Salamone, Pier Paolo Quarato, Liliana Graciela Grammaldo, Maddalena Dal Pozzo, Damiano Abeni, Giancarlo Di Gennaro   +8 more
wiley   +1 more source

SIGNOR 4.0: the 2025 update with focus on phosphorylation data. [PDF]

Nucleic Acids Res
Lo Surdo P, Iannuccelli M, Karis K, Meo E, Omidi P, Tosoni M, Graziosi S, Panni S, Fiorillo MT, Licata L, Sacco F, Gyori BM, Perfetto L.   +12 more
europepmc   +1 more source